English

AURORA BIOSCIENCES CORP

EDGAR

Quarterly report (10-Q) · filed 2001-05-11

18 filing records in this dataset, filed from 1997-08-14 to 2001-05-11. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

17.5 million USD

2001-03-31 · USD

Exact inputs and evidence

Revenue: 17520683 USD Source

Operating margin

-17.5%

2001-03-31 · %

Exact inputs and evidence

Operating Income: -3065592 USD Source
Revenue: 17520683 USD Source

Operating cash flow

-1.22 million USD

2001-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1219250 USD Source

Free cash flow

-7.23 million USD

2001-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1219250 USD Source
Capital Expenditure: 6008778 USD Source

Cash and cash equivalents: 10.4 million USD 2001-03-31 Source
Exact value

10367314 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

68.5 million USD

2000-04-01 – 2001-03-31

Exact inputs and evidence

Revenue: 17529110 USD · 2000-04-01 – 2000-06-30 Source
Revenue: 16793549 USD · 2000-07-01 – 2000-09-30 Source
Revenue: 63790611 USD · 2000-01-01 – 2000-12-31 Source
Revenue: 47122899 USD · 2000-01-01 – 2000-09-30 Source
Revenue: 17520683 USD · 2001-01-01 – 2001-03-31 Source

Net income

2.6 million USD

2000-04-01 – 2001-03-31

Exact inputs and evidence

Net income: 4231867 USD · 2000-04-01 – 2000-06-30 Source
Net income: 1403311 USD · 2000-07-01 – 2000-09-30 Source
Net income: 4353426 USD · 2000-01-01 – 2000-12-31 Source
Net income: 5663070 USD · 2000-01-01 – 2000-09-30 Source
Net income: -1721774 USD · 2001-01-01 – 2001-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-05-11.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2000-12-31
Operating income: 5 of 11 periods available· newest 2000-12-31
Net income: 5 of 11 periods available· newest 2000-12-31
Operating cash flow: 5 of 11 periods available· newest 2000-12-31
Capital expenditure: 5 of 11 periods available· newest 2000-12-31
Total assets: 5 of 11 periods available· newest 2000-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2000-12-31
Current liabilities: 5 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+26.3%

Prior period

USD 50.52 million

1999-01-01 – 1999-12-31
Current period

USD 63.79 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

63790611 − 50521461 = 13269150 USD

50521461 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
63790611 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Year-over-year change in Revenue: 13269150 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 63790611 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#2967 Input fundies:Revenue: 50521461 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#2967
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.56 million

Prior period

−USD 209,317

1999-01-01 – 1999-12-31
Current period

USD 4.35 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

4353426 − -209317 = 4562743 USD

-209317 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
4353426 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Year-over-year change in Net income: 4562743 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 4353426 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3128 Input fundies:NetIncome: -209317 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3128
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-118.5%

Prior period

USD 9.15 million

1999-01-01 – 1999-12-31
Current period

−USD 1.69 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-1694047 − 9154089 = -10848136 USD

9154089 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-1694047 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Year-over-year change in Operating cash flow: -10848136 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1694047 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 Input fundies:OperatingCashFlow: 9154089 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+154.8%

Prior period

USD 1.59 million

1999-01-01 – 1999-12-31
Current period

USD 4.04 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

4044483 − 1587219 = 2457264 USD

1587219 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
4044483 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Year-over-year change in Capital expenditure: 2457264 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4044483 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 Input fundies:CapitalExpenditure: 1587219 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 63.79 million 100% of revenue
Operating costs Derived USD 63.4 million 99% of revenue
Operating income USD 388,632 0.6% of revenue
Tax, interest and other Derived −USD 3.96 million −6.2% of revenue
Net income USD 4.35 million 6.8% of revenue

Cash

Operating cash flow −USD 1.69 million −2.7% of revenue
Capital expenditure USD 4.04 million 6.3% of revenue
Free cash flow Derived −USD 5.74 million −9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Operating loss: operating costs were 256% of revenue.
1997 Operating loss: operating costs were 108% of revenue.
1998 Operating loss: operating costs were 177% of revenue.
1999 Operating loss: operating costs were 102% of revenue.
2000 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	2216523	5670946 Derived	-3454423	-520943 Derived	-2933480	-4088677 Derived	Source 1996-01-01 – 1996-12-31: 2216523 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -3454423 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -2933480 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -3630020 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 458657 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	14907749	16067923 Derived	-1160174	-1427508 Derived	267334	298010 Derived	Source 1997-01-01 – 1997-12-31: 14907749 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -1160174 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: 267334 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 2249786 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 1951776 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	26557888	47064004 Derived	-20506116	-1799441 Derived	-18706675	-17549487 Derived	Source 1998-01-01 – 1998-12-31: 26557888 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -20506116 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -18706675 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -14708973 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2840514 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	50521461	51468000 Derived	-946539	-737222 Derived	-209317	7566870 Derived	Source 1999-01-01 – 1999-12-31: 50521461 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -946539 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -209317 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 9154089 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1587219 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	63790611	63401979 Derived	388632	-3964794 Derived	4353426	-5738530 Derived	Source 2000-01-01 – 2000-12-31: 63790611 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 388632 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 4353426 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -1694047 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 4044483 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 63.8M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	2216523	Revenue: 2216523 Open source
19971997-12-31	Revenue	14907749	Revenue: 14907749 Open source
19981998-12-31	Revenue	26557888	Revenue: 26557888 Open source
19991999-12-31	Revenue	50521461	Revenue: 50521461 Open source
20002000-12-31	Revenue	63790611	Revenue: 63790611 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

26.3% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 2216523 Open source
19971997-12-31	Year over year	572.6%	Revenue: 14907749 Open source Revenue: 2216523 Open source
19981998-12-31	Year over year	78.1%	Revenue: 26557888 Open source Revenue: 14907749 Open source
19991999-12-31	Year over year	90.2%	Revenue: 50521461 Open source Revenue: 26557888 Open source
20002000-12-31	Year over year	26.3%	Revenue: 63790611 Open source Revenue: 50521461 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.6% 2000

Net margin 6.8% 2000

Free cash flow margin -9% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Operating margin	-155.8%	Operating Income: -3454423 Open source Revenue: 2216523 Open source
19971997-12-31	Operating margin	-7.8%	Operating Income: -1160174 Open source Revenue: 14907749 Open source
19981998-12-31	Operating margin	-77.2%	Operating Income: -20506116 Open source Revenue: 26557888 Open source
19991999-12-31	Operating margin	-1.9%	Operating Income: -946539 Open source Revenue: 50521461 Open source
20002000-12-31	Operating margin	0.6%	Operating Income: 388632 Open source Revenue: 63790611 Open source
19961996-12-31	Net margin	-132.3%	Net Income: -2933480 Open source Revenue: 2216523 Open source
19971997-12-31	Net margin	1.8%	Net Income: 267334 Open source Revenue: 14907749 Open source
19981998-12-31	Net margin	-70.4%	Net Income: -18706675 Open source Revenue: 26557888 Open source
19991999-12-31	Net margin	-0.4%	Net Income: -209317 Open source Revenue: 50521461 Open source
20002000-12-31	Net margin	6.8%	Net Income: 4353426 Open source Revenue: 63790611 Open source
19961996-12-31	Free cash flow margin	-184.5%	Revenue: 2216523 Open source Operating Cash Flow: -3630020 Open source Capital Expenditure: 458657 Open source
19971997-12-31	Free cash flow margin	2%	Revenue: 14907749 Open source Operating Cash Flow: 2249786 Open source Capital Expenditure: 1951776 Open source
19981998-12-31	Free cash flow margin	-66.1%	Revenue: 26557888 Open source Operating Cash Flow: -14708973 Open source Capital Expenditure: 2840514 Open source
19991999-12-31	Free cash flow margin	15%	Revenue: 50521461 Open source Operating Cash Flow: 9154089 Open source Capital Expenditure: 1587219 Open source
20002000-12-31	Free cash flow margin	-9%	Revenue: 63790611 Open source Operating Cash Flow: -1694047 Open source Capital Expenditure: 4044483 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.7M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-3630020	Operating Cash Flow: -3630020 Open source
19971997-12-31	Operating cash flow	2249786	Operating Cash Flow: 2249786 Open source
19981998-12-31	Operating cash flow	-14708973	Operating Cash Flow: -14708973 Open source
19991999-12-31	Operating cash flow	9154089	Operating Cash Flow: 9154089 Open source
20002000-12-31	Operating cash flow	-1694047	Operating Cash Flow: -1694047 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5.7M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-4088677	Operating Cash Flow: -3630020 Open source Capital Expenditure: 458657 Open source
19971997-12-31	Free cash flow	298010	Operating Cash Flow: 2249786 Open source Capital Expenditure: 1951776 Open source
19981998-12-31	Free cash flow	-17549487	Operating Cash Flow: -14708973 Open source Capital Expenditure: 2840514 Open source
19991999-12-31	Free cash flow	7566870	Operating Cash Flow: 9154089 Open source Capital Expenditure: 1587219 Open source
20002000-12-31	Free cash flow	-5738530	Operating Cash Flow: -1694047 Open source Capital Expenditure: 4044483 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 17514524 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 63035832 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 50954716 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 64007176 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 168255284 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.34× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	12.03×	Current Assets: 14680635 Open source Current Liabilities: 1219836 Open source
19971997-12-31	Current assets / current liabilities	10.49×	Current Assets: 53439937 Open source Current Liabilities: 5095762 Open source
19981998-12-31	Current assets / current liabilities	3.89×	Current Assets: 33566374 Open source Current Liabilities: 8624779 Open source
19991999-12-31	Current assets / current liabilities	2.34×	Current Assets: 45141062 Open source Current Liabilities: 19251701 Open source
20002000-12-31	Current assets / current liabilities	4.34×	Current Assets: 135420302 Open source Current Liabilities: 31185551 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	−USD 2.93 million Exact value Exact value: -2933480 USD 1996-01-01 – 1996-12-31: -2933480 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURORA BIOSCIENCES CORP · 1996-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Net Income: -2933480 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2933480 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001047469-99-012988.txt#2745 The citation records this snapshot. The page link may show a newer release later.	−USD 3.63 million Exact value Exact value: -3630020 USD 1996-01-01 – 1996-12-31: -3630020 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURORA BIOSCIENCES CORP · 1996-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Operating Cash Flow: -3630020 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3630020 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001047469-99-012988.txt#2763 The citation records this snapshot. The page link may show a newer release later.	USD 458,657 Exact value Exact value: 458657 USD 1996-01-01 – 1996-12-31: 458657 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURORA BIOSCIENCES CORP · 1996-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Capital Expenditure: 458657 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 458657 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001047469-99-012988.txt#2767 The citation records this snapshot. The page link may show a newer release later.	−USD 4.09 million Calculation and evidence -3630020 − 458657 USD Exact free cash flow: -4088677 USD 1996-01-01 – 1996-12-31: -3630020 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 458657 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURORA BIOSCIENCES CORP · 1996-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Free cash flow: -4088677 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3630020 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001047469-99-012988.txt#2763 Input fundies:CapitalExpenditure: 458657 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001047469-99-012988.txt#2767 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 267,334 Exact value Exact value: 267334 USD 1997-01-01 – 1997-12-31: 267334 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURORA BIOSCIENCES CORP · 1997-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Net Income: 267334 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 267334 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0000936392-00-000142.txt#2954 The citation records this snapshot. The page link may show a newer release later.	USD 2.25 million Exact value Exact value: 2249786 USD 1997-01-01 – 1997-12-31: 2249786 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURORA BIOSCIENCES CORP · 1997-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Operating Cash Flow: 2249786 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2249786 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0000936392-00-000142.txt#2971 The citation records this snapshot. The page link may show a newer release later.	USD 1.95 million Exact value Exact value: 1951776 USD 1997-01-01 – 1997-12-31: 1951776 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURORA BIOSCIENCES CORP · 1997-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Capital Expenditure: 1951776 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1951776 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0000936392-00-000142.txt#2975 The citation records this snapshot. The page link may show a newer release later.	USD 298,010 Calculation and evidence 2249786 − 1951776 USD Exact free cash flow: 298010 USD 1997-01-01 – 1997-12-31: 2249786 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 1951776 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURORA BIOSCIENCES CORP · 1997-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Free cash flow: 298010 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2249786 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0000936392-00-000142.txt#2971 Input fundies:CapitalExpenditure: 1951776 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0000936392-00-000142.txt#2975 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 18.71 million Exact value Exact value: -18706675 USD 1998-01-01 – 1998-12-31: -18706675 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURORA BIOSCIENCES CORP · 1998-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Net Income: -18706675 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18706675 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3128 The citation records this snapshot. The page link may show a newer release later.	−USD 14.71 million Exact value Exact value: -14708973 USD 1998-01-01 – 1998-12-31: -14708973 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURORA BIOSCIENCES CORP · 1998-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Operating Cash Flow: -14708973 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14708973 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 2.84 million Exact value Exact value: 2840514 USD 1998-01-01 – 1998-12-31: 2840514 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURORA BIOSCIENCES CORP · 1998-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Capital Expenditure: 2840514 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2840514 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.	−USD 17.55 million Calculation and evidence -14708973 − 2840514 USD Exact free cash flow: -17549487 USD 1998-01-01 – 1998-12-31: -14708973 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2840514 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURORA BIOSCIENCES CORP · 1998-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Free cash flow: -17549487 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14708973 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 Input fundies:CapitalExpenditure: 2840514 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 209,317 Exact value Exact value: -209317 USD 1999-01-01 – 1999-12-31: -209317 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURORA BIOSCIENCES CORP · 1999-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Net Income: -209317 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -209317 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3128 The citation records this snapshot. The page link may show a newer release later.	USD 9.15 million Exact value Exact value: 9154089 USD 1999-01-01 – 1999-12-31: 9154089 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURORA BIOSCIENCES CORP · 1999-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Operating Cash Flow: 9154089 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9154089 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 1.59 million Exact value Exact value: 1587219 USD 1999-01-01 – 1999-12-31: 1587219 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURORA BIOSCIENCES CORP · 1999-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Capital Expenditure: 1587219 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1587219 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.	USD 7.57 million Calculation and evidence 9154089 − 1587219 USD Exact free cash flow: 7566870 USD 1999-01-01 – 1999-12-31: 9154089 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1587219 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURORA BIOSCIENCES CORP · 1999-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Free cash flow: 7566870 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9154089 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 Input fundies:CapitalExpenditure: 1587219 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 4.35 million Exact value Exact value: 4353426 USD 2000-01-01 – 2000-12-31: 4353426 USD Inspect Net Income Open source Share or cite Citation for Net Income · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Net Income: 4353426 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4353426 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3128 The citation records this snapshot. The page link may show a newer release later.	−USD 1.69 million Exact value Exact value: -1694047 USD 2000-01-01 – 2000-12-31: -1694047 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Operating Cash Flow: -1694047 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1694047 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 The citation records this snapshot. The page link may show a newer release later.	USD 4.04 million Exact value Exact value: 4044483 USD 2000-01-01 – 2000-12-31: 4044483 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Capital Expenditure: 4044483 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4044483 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.	−USD 5.74 million Calculation and evidence -1694047 − 4044483 USD Exact free cash flow: -5738530 USD 2000-01-01 – 2000-12-31: -1694047 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 4044483 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AURORA BIOSCIENCES CORP · 2000-12-31 AURORA BIOSCIENCES CORP (edgar:1010919) Free cash flow: -5738530 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-11T23:13:04Z Snapshot: d08296820a63b516e513e57329de34b5ea442fcb2d251488752bb97dc47da8da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1694047 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3146 Input fundies:CapitalExpenditure: 4044483 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010919/0001095811-01-001621.txt#3150 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-11. Source filing dates and reporting periods are shown separately.

Identifiers: 0001010919, 1010919, edgar:1010919

AURORA BIOSCIENCES CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation